IIQ ASX · Health Care

Inoviq Ltd

Announcements, last 12 months
40
Price sensitive, last 12 months
14
Followed on InvestorPA
Low (Outside the 20% most-followed companies on InvestorPA)

Upcoming events

INOVIQ LIMITED ACN 009 070 384 Annual General Meeting

Latest announcements

Released Headline Actions
Notice of Annual General Meeting/Proxy Form
INOVIQ Announces Leadership Change Price sensitive AI summary
EXO-OC Technical Review and Commercialisation Pathway Price sensitive AI summary
2026 Annual Report
Appendix 4G and Corporate Governance Statement
Appendix 4E and Preliminary Financial Report Price sensitive AI summary
Becoming a substantial holder
Change of Director's Interest Notice
EXO-OC Study Outcome Investor Webinar Presentation Price sensitive AI summary
Quarterly Activities Report and Appendix 4C - June 2026 Price sensitive AI summary

Sign in to see all IIQ announcements.

Guidance history

27 Aug 2026 FY26 revenue: $432,047, Net loss: $7,505,123, Cash: $9.4 million
14 Jul 2026 INOVIQ aims to minimize impact on development and commercialization timelines for EXO-OC
13 Jul 2026 Inoviq Ltd has A$9.353m cash at 30 June 2026, with FY26 project spend totaling A$1.216m.

Sign in to see the full guidance history.

Most followed in Health Care

  • PME Pro Medicus Ltd
  • AHC Austco Healthcare Ltd
  • CSL CSL Ltd
  • RMD Resmed Inc
  • TLX TELIX Pharmaceuticals Ltd
  • CGS Cogstate Ltd
  • ALC Alcidion Group Ltd
  • CSX Cleanspace Holdings Ltd
Follow IIQ to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in